Vertex Pharmaceuticals controversies
Controversies tied to this brand in public sources. A listing is not a finding of fault.
Back to profile3 entries
2019
Expired Orkambi packs destroyed during NHS negotiations
Vertex was reported to have destroyed 7,880 packs of Orkambi after they expired during negotiations with the UK's National Health Service, intensifying public criticism of the access dispute.
2019
Access and generic-competition criticism over Trikafta
Advocacy groups and commentators criticized Vertex's international availability policies and efforts to protect its intellectual-property position, arguing that patients in lower-income countries faced limited access.
2015
Criticism of cystic fibrosis medicine pricing
Physicians, patient advocates and commentators criticized the prices of Vertex's CF medicines, arguing that high annual costs could restrict access despite the medicines' clinical value.